glp 1 drugs and blood clots A recent study suggests that GLP-1 medications, commonly prescribed for managing diabetes obesity, may also lower the risk of dangerous clots., The study’s lead author, Dr. Rushad Patell of GLP-1 Medications Infographic | Medidex
Description
00:10:40 Vickie Danaher So the bottom line in this case is the switch may be reasonable, but only if Jay can reliably follow the strict daily dosing requirements with the oral medication
Common side effects (from clinical trial data): Nausea affects roughly 44% of users Diarrhea 30% Vomiting 24% Constipation 24% Abdominal pain 20% These are the main reasons most people stop taking these drugs
Increasing gradually gives your body time to adapt and helps you find the most effective dose for ongoing weight loss
The extended release microsphere formulation provides sustained exenatide levels throughout the week producing effective glycemic control and modest weight loss
This study aimed to summarize these indicators through a meta-analysis
